Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

L-serine treatment in patients with GRIN-related encephalopathy: a phase 2A, non-randomized study
Natalia Juliá‐Palacios, Mireia Olivella, Mariya Sigatullina Bondarenko, et al.
Brain (2024) Vol. 147, Iss. 5, pp. 1653-1666
Closed Access | Times Cited: 10

Showing 10 citing articles:

Developmental and epileptic encephalopathies
Ingrid E. Scheffer, Sameer M. Zuberi, Heather C. Mefford, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 21
International Precision Child Health Partnership (IPCHiP): an initiative to accelerate discovery and improve outcomes in rare pediatric disease
Katherine B. Howell, Susan M. White, Amy McTague, et al.
npj Genomic Medicine (2025) Vol. 10, Iss. 1
Open Access
Spermidine Treatment Improves GRIN2B Loss‐Of‐Function, A Primary Disorder of Glutamatergic Neurotransmission
Ana Santos‐Gómez, Natalia Juliá‐Palacios, A. Rejano‐Bosch, et al.
Journal of Inherited Metabolic Disease (2025) Vol. 48, Iss. 2
Open Access
Current and Emerging Precision Therapies for Developmental and Epileptic Encephalopathies
Debopam Samanta, Sonal Bhatia, Senyene E. Hunter, et al.
Pediatric Neurology (2025) Vol. 168, pp. 67-81
Closed Access
Single Amino Acid Supplementation in Inherited Metabolic Disorders: An Evidence-Based Review of Interventions
Elvira Verduci, Martina Tosi, Carlo Dionisi‐Vici, et al.
Genes (2025) Vol. 16, Iss. 5, pp. 502-502
Open Access
Advances and challenges in serine in the central nervous system: physicochemistry, physiology, and pharmacology
Jia‐Meng Li, Ya‐Zhi Bai, Shuang‐Qing Zhang
Metabolic Brain Disease (2024) Vol. 39, Iss. 8, pp. 1637-1647
Closed Access | Times Cited: 1
L-serine treatment in a patient with refractory epilepsy due to a GRIN2A missense mutation
Hui Jin Shin, Ara Ko, Se Hee Kim, et al.
Acta Neurologica Belgica (2024)
Closed Access
Context matters: Integrative NMDA receptor dysfunction reveals effective seizure treatment in mice with a human patient GluN1 variant
Sridevi Venkatesan, Daria Nazarkina, Megan T. Sullivan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Therapeutic Implications of Recent Genomic Discoveries in Schizophrenia
Steven J. Clapcote
Royal Society of Chemistry eBooks (2024), pp. 225-241
Closed Access
Population pharmacokinetic and pharmacodynamic model guided weight-tiered dose of AST-001 in pediatric patients with autism spectrum disorder
Soyoung Lee, Su‐Kyeong Hwang, Jung-Sook Cho, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Page 1

Scroll to top